Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

catalyst · primary record

EMPAGLIFLOZIN

FDA filing · 2026-09-17

CompanyRIDHISIDHI, PLLC
TickerNot stated
Impactmedium
DetailOriginal Application · Tentative Approval
SourceopenFDA

Provenance

  • Source: openFDA
  • Fetched at: 2026-10-30T14:45:46.899Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: RIDHISIDHI, PLLC:EMPAGLIFLOZIN:2026-09-17:Original Application · Tentative Approval

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Same entity, elsewhere in the suite